159 related articles for article (PubMed ID: 38621994)
1. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel
Meqbil YJ; Aguilar J; Blaine AT; Chen L; Cassell RJ; Pradhan AA; van Rijn RM
J Pharmacol Exp Ther; 2024 May; 389(3):301-309. PubMed ID: 38621994
[No Abstract] [Full Text] [Related]
2. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
[TBL] [Abstract][Full Text] [Related]
3. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
[TBL] [Abstract][Full Text] [Related]
4. Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance.
Pradhan AA; Walwyn W; Nozaki C; Filliol D; Erbs E; Matifas A; Evans C; Kieffer BL
J Neurosci; 2010 Dec; 30(49):16459-68. PubMed ID: 21147985
[TBL] [Abstract][Full Text] [Related]
5. 3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
Bishop MJ; Garrido DM; Boswell GE; Collins MA; Harris PA; McNutt RW; O'Neill SJ; Wei K; Chang KJ
J Med Chem; 2003 Feb; 46(4):623-33. PubMed ID: 12570383
[TBL] [Abstract][Full Text] [Related]
6. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
Stevenson GW; Folk JE; Rice KC; Negus SS
J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
[TBL] [Abstract][Full Text] [Related]
7. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers.
Furness MS; Zhang X; Coop A; Jacobson AE; Rothman RB; Dersch CM; Xu H; Porreca F; Rice KC
J Med Chem; 2000 Aug; 43(16):3193-6. PubMed ID: 10956228
[TBL] [Abstract][Full Text] [Related]
8. β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake.
Chiang T; Sansuk K; van Rijn RM
Br J Pharmacol; 2016 Jan; 173(2):332-43. PubMed ID: 26507558
[TBL] [Abstract][Full Text] [Related]
9. δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.
Nozaki C; Le Bourdonnec B; Reiss D; Windh RT; Little PJ; Dolle RE; Kieffer BL; Gavériaux-Ruff C
J Pharmacol Exp Ther; 2012 Sep; 342(3):799-807. PubMed ID: 22700431
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities.
Meqbil YJ; Su H; Cassell RJ; Mores KL; Gutridge AM; Cummins BR; Chen L; van Rijn RM
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885825
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
[TBL] [Abstract][Full Text] [Related]
12. Agonist-specific down-regulation of the human delta-opioid receptor.
Okura T; Varga EV; Hosohata Y; Navratilova E; Cowell SM; Rice K; Nagase H; Hruby VJ; Roeske WR; Yamamura HI
Eur J Pharmacol; 2003 Jan; 459(1):9-16. PubMed ID: 12505529
[TBL] [Abstract][Full Text] [Related]
13. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
Jutkiewicz EM; Kaminsky ST; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2005 Oct; 315(1):414-22. PubMed ID: 16014751
[TBL] [Abstract][Full Text] [Related]
14. Spinal delta-opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat.
Cao CQ; Hong Y; Dray A; Perkins M
Eur J Pharmacol; 2001 Apr; 418(1-2):79-87. PubMed ID: 11334868
[TBL] [Abstract][Full Text] [Related]
15. Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety.
van Rijn RM; Brissett DI; Whistler JL
J Pharmacol Exp Ther; 2010 Oct; 335(1):133-9. PubMed ID: 20605909
[TBL] [Abstract][Full Text] [Related]
16. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.
Jutkiewicz EM; Eller EB; Folk JE; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2004 Apr; 309(1):173-81. PubMed ID: 14722329
[TBL] [Abstract][Full Text] [Related]
17. Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis.
Banks ML; Roma PG; Folk JE; Rice KC; Negus SS
Psychopharmacology (Berl); 2011 Aug; 216(3):431-9. PubMed ID: 21369752
[TBL] [Abstract][Full Text] [Related]
18. Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.
Dripps IJ; Bertels Z; Moye LS; Tipton AF; Siegersma K; Baca SM; Kieffer BL; Pradhan AA
Sci Rep; 2020 Oct; 10(1):17629. PubMed ID: 33077757
[TBL] [Abstract][Full Text] [Related]
19. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
20. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2006 Jun; 317(3):1337-48. PubMed ID: 16537798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
